Neuroscience and the Near-Death Experience: Roles for the NMSA-PCP receptor, the sigma receptor and the endopsychosins
Medical Hypotheses January 1, 1990 DOI: 10.1016/0306-9877(90)90048-j via OpenAlex
Summary
AI-generated from the abstractThe near-death experience (NDE) is a dissociative mental state with characteristic features that can be reproduced by ketamine, which acts at sigma sites and blocks NMDA-linked PCP receptors to reduce ischemic damage. Endogenous ligands, alpha and beta-endopsychosin, have been detected for these receptors, suggesting an explanation for some NDEs: the endopsychosins may be released in abnormal quantity to protect neurons from ischemic and other excitotoxic damage, and the NDE is a side effect on consciousness with important psychological functions.
Study at a glance
| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Topics | Ketamine |
| Keywords | Phencyclidine Nmda receptor Neuroscience Sigma receptor |
| Citations | 96 |
| Key finding | Endopsychosins may be released in abnormal quantity to protect neurons from ischemic and excitotoxic damage, and the NDE is a side effect on consciousness with important psychological functions. |
Abstract
The Near-Death Experience (NDE) is a dissociative mental state with characteristic features. These can be reproduced by ketamine which acts at sigma sites and blocks N-methyl-D-aspartate (NMDA) linked phencyclidine (PCP) receptors to reduce ischaemic damage. Endogenous ligands, alpha and beta-endopsychosin, have been detected for these receptors which suggests an explanation for some NDE's: the endopsychosins may be released in abnormal quantity to protect neurons from ischaemic and other excitotoxic damage, and the NDE is a side effect on consciousness with important psychological functions.